Skip to main content
Erschienen in: Clinical Rheumatology 9/2008

01.09.2008 | Brief Report

Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly

verfasst von: Angela G. Juby, Paul Davis

Erschienen in: Clinical Rheumatology | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Canadian Consensus guidelines regarding appropriate use of nonsteroidal anti-inflammatory drugs (NSAID) were recently published. This study was done to evaluate the application of these guidelines on NSAID practice patterns in frail elderly patients referred to a specialist Geriatric Assessment Clinic. A retrospective chart review was undertaken of referrals who were currently prescribed NSAIDs. Data were captured on age, sex, weight, diagnoses, medications and dosages, indication for NSAID treatment, lying BP (as assessed in the clinic) and recent serum creatinine result. Creatinine clearance was subsequently calculated use the Cockcroft–Gault equation. Complete data were available on 107 patients (68% women, average age 80.6 years). Thirty percent were on a traditional NSAID, the remainder were on a Coxib. Concomitant aspirin was prescribed in 37%. Cytoprotection was being used in 38% and did not increase appreciably in patients with additional risk factors for GI toxicity, i.e., concomitant aspirin usage(35%), and history of GI toxicity (48%). Sixty-seven were taking anti-hypertensive medications, although more than two thirds of these patients were uncontrolled. Newly diagnosed hypertension was present in 19.6%. Calculated creatinine clearance revealed moderate to severe renal impairment in 79% of subjects, although serum creatinine was only elevated in 18%. In total, 70% of subjects were found to have relative or absolute risk factors for NSAID therapy. Given the high prevalence of potential contraindications to anti-inflammatory drug usage in this study, we advocate the dissemination and application of these guidelines in geriatric patients in an attempt to reduce potential morbidity and mortality.
Literatur
1.
Zurück zum Zitat Tannenbaum H, Bombardier C, Davis P, Russell AS (2006) Third Canadian Consensus Conference Group. An evidence-based approach to prescribing nonsteroidal anti-inflammatory drugs. Third Canadian Consensus Conference. J Rheumatol 33(1):140–157PubMed Tannenbaum H, Bombardier C, Davis P, Russell AS (2006) Third Canadian Consensus Conference Group. An evidence-based approach to prescribing nonsteroidal anti-inflammatory drugs. Third Canadian Consensus Conference. J Rheumatol 33(1):140–157PubMed
2.
Zurück zum Zitat Tannenbaum H, Davis P, Russell AS et al (1996) An evidence based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus participants. CMAJ 155:77–88PubMed Tannenbaum H, Davis P, Russell AS et al (1996) An evidence based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus participants. CMAJ 155:77–88PubMed
3.
Zurück zum Zitat Tannenbaum H, Peloso PMJ, Russell AS, Marlow B (2000) An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol 7(Suppl A):4A–16APubMed Tannenbaum H, Peloso PMJ, Russell AS, Marlow B (2000) An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol 7(Suppl A):4A–16APubMed
4.
Zurück zum Zitat Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and Rheumatoid Arthritis: the CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284(10):1247–1255PubMedCrossRef Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and Rheumatoid Arthritis: the CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284(10):1247–1255PubMedCrossRef
5.
Zurück zum Zitat Whelton A, Schulman G, Wallemark C et al (2000) Effect of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 169:1465–1470CrossRef Whelton A, Schulman G, Wallemark C et al (2000) Effect of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 169:1465–1470CrossRef
6.
Zurück zum Zitat Sonomon DH, Schneeweiss S, Levin R, Avorn J (2004) Relationship between COX-2 specific inhibitors and hypertension. Hypertension 44:140–145CrossRef Sonomon DH, Schneeweiss S, Levin R, Avorn J (2004) Relationship between COX-2 specific inhibitors and hypertension. Hypertension 44:140–145CrossRef
7.
Zurück zum Zitat Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR (2002) Non-steroidal and anti-inflammatory drugs and risk of serious coronary heart disease: an observational study. Lancet 359:118–123PubMedCrossRef Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR (2002) Non-steroidal and anti-inflammatory drugs and risk of serious coronary heart disease: an observational study. Lancet 359:118–123PubMedCrossRef
8.
Zurück zum Zitat Visser LE, Graatsma HH, Tricker BHC (2002) Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol 53:183–188PubMedCrossRef Visser LE, Graatsma HH, Tricker BHC (2002) Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol 53:183–188PubMedCrossRef
9.
Zurück zum Zitat Abraham NS, El-Serag HB, Johnson ML (2005) National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. J Gastroenterol 129:1171–1178CrossRef Abraham NS, El-Serag HB, Johnson ML (2005) National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. J Gastroenterol 129:1171–1178CrossRef
10.
Zurück zum Zitat Van Leen MWF, Van Der Eijk I, Schols JMGA (2007) Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. Age Ageing 36:414–418PubMedCrossRef Van Leen MWF, Van Der Eijk I, Schols JMGA (2007) Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. Age Ageing 36:414–418PubMedCrossRef
11.
Zurück zum Zitat Catella-Lawson F, Reilly MP, Kapoor SC et al (200) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809–1817CrossRef Catella-Lawson F, Reilly MP, Kapoor SC et al (200) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809–1817CrossRef
12.
Zurück zum Zitat Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359:14–22PubMedCrossRef Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359:14–22PubMedCrossRef
13.
Zurück zum Zitat Loke YK, Trivedi AN, Singh S (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31–40PubMedCrossRef Loke YK, Trivedi AN, Singh S (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31–40PubMedCrossRef
14.
Zurück zum Zitat Davis P, Juby A (2007) Osteoarthritis. Therapeutic choices, 5th edn., Chapter 71. Canadian Pharmacists Association, Canada, pp 939–952 Davis P, Juby A (2007) Osteoarthritis. Therapeutic choices, 5th edn., Chapter 71. Canadian Pharmacists Association, Canada, pp 939–952
Metadaten
Titel
Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly
verfasst von
Angela G. Juby
Paul Davis
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 9/2008
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0952-7

Weitere Artikel der Ausgabe 9/2008

Clinical Rheumatology 9/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.